Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 31

    1.

    The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.

    Muehlich S, Hampl V, Khalid S, Singer S, Frank N, Breuhahn K, Gudermann T, Prywes R.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.560. [Epub ahead of print]

    PMID:
    22139079
    [PubMed - as supplied by publisher]
    2.

    Acetylation controls Notch3 stability and function in T-cell leukemia.

    Palermo R, Checquolo S, Giovenco A, Grazioli P, Kumar V, Campese AF, Giorgi A, Napolitano M, Canettieri G, Ferrara G, Schininà ME, Maroder M, Frati L, Gulino A, Vacca A, Screpanti I.

    Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.533. [Epub ahead of print]

    PMID:
    22120716
    [PubMed - as supplied by publisher]
    3.

    Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia.

    Tailler M, Senovilla L, Lainey E, Thépot S, Métivier D, Sébert M, Baud V, Billot K, Fenaux P, Galluzzi L, Boehrer S, Kroemer G, Kepp O.

    Oncogene. 2011 Nov 21. doi: 10.1038/onc.2011.521. [Epub ahead of print]

    PMID:
    22105358
    [PubMed - as supplied by publisher]
    4.

    Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.

    Sriram G, Reichman C, Tunceroglu A, Kaushal N, Saleh T, Machida K, Mayer B, Ge Q, Li J, Hornbeck P, Kalodimos CG, Birge RB.

    Oncogene. 2011 Nov 17;30(46):4645-55. doi: 10.1038/onc.2011.170. Epub 2011 May 23.

    PMID:
    21602891
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Further activation of FLT3 mutants by FLT3 ligand.

    Zheng R, Bailey E, Nguyen B, Yang X, Piloto O, Levis M, Small D.

    Oncogene. 2011 Sep 22;30(38):4004-14. doi: 10.1038/onc.2011.110. Epub 2011 Apr 25.

    PMID:
    21516120
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.

    Ånensen N, Hjelle SM, Van Belle W, Haaland I, Silden E, Bourdon JC, Hovland R, Taskén K, Knappskog S, Lønning PE, Bruserud Ø, Gjertsen BT.

    Oncogene. 2012 Mar 22;31(12):1533-45. doi: 10.1038/onc.2011.348. Epub 2011 Aug 22.

    PMID:
    21860418
    [PubMed - indexed for MEDLINE]
    7.

    Error occurred: cannot get document summary

    PMID:
    21697952

    8.

    Retraction. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.

    [No authors listed]

    Oncogene. 2011 Jun 16;30(24):2798. doi: 10.1038/onc.2011.67. No abstract available.

    PMID:
    21677655
    [PubMed - indexed for MEDLINE]
    9.

    Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen.

    Tauchi T, Okabe S, Ashihara E, Kimura S, Maekawa T, Ohyashiki K.

    Oncogene. 2011 Jun 16;30(24):2789-97. doi: 10.1038/onc.2011.3. Epub 2011 Jan 31.

    PMID:
    21278787
    [PubMed - indexed for MEDLINE]
    10.

    MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.

    Zheng YS, Zhang H, Zhang XJ, Feng DD, Luo XQ, Zeng CW, Lin KY, Zhou H, Qu LH, Zhang P, Chen YQ.

    Oncogene. 2012 Jan 5;31(1):80-92. doi: 10.1038/onc.2011.208. Epub 2011 Jun 6.

    PMID:
    21643017
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.

    Mochmann LH, Bock J, Ortiz-Tánchez J, Schlee C, Bohne A, Neumann K, Hofmann WK, Thiel E, Baldus CD.

    Oncogene. 2011 Apr 28;30(17):2044-56. Epub 2011 Jan 17.

    PMID:
    21242973
    [PubMed - indexed for MEDLINE]
    12.

    Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis.

    Altman BJ, Jacobs SR, Mason EF, Michalek RD, MacIntyre AN, Coloff JL, Ilkayeva O, Jia W, He YW, Rathmell JC.

    Oncogene. 2011 Apr 21;30(16):1855-67. Epub 2010 Dec 13.

    PMID:
    21151168
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.

    Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L.

    Oncogene. 2011 Aug 4;30(31):3416-28. doi: 10.1038/onc.2011.62. Epub 2011 Mar 14.

    PMID:
    21399664
    [PubMed - indexed for MEDLINE]
    14.

    The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro.

    von Bubnoff N, Gorantla SP, Engh RA, Oliveira TM, Thöne S, Aberg E, Peschel C, Duyster J.

    Oncogene. 2011 Feb 24;30(8):933-43. Epub 2010 Oct 25.

    PMID:
    20972453
    [PubMed - indexed for MEDLINE]
    15.

    Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.

    Dettman EJ, Simko SJ, Ayanga B, Carofino BL, Margolin JF, Morse HC 3rd, Justice MJ.

    Oncogene. 2011 Jun 23;30(25):2859-73. doi: 10.1038/onc.2011.12. Epub 2011 Feb 21.

    PMID:
    21339739
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Epigenetic regulations in hematopoietic Hox code.

    He H, Hua X, Yan J.

    Oncogene. 2011 Jan 27;30(4):379-88. Epub 2010 Oct 25. Review.

    PMID:
    20972460
    [PubMed - indexed for MEDLINE]
    17.

    BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.

    De Carvalho DD, Binato R, Pereira WO, Leroy JM, Colassanti MD, Proto-Siqueira R, Bueno-Da-Silva AE, Zago MA, Zanichelli MA, Abdelhay E, Castro FA, Jacysyn JF, Amarante-Mendes GP.

    Oncogene. 2011 Jan 13;30(2):223-33. Epub 2010 Sep 13.

    PMID:
    20838376
    [PubMed - indexed for MEDLINE]
    18.

    Hedgehog signaling maintains chemoresistance in myeloid leukemic cells.

    Queiroz KC, Ruela-de-Sousa RR, Fuhler GM, Aberson HL, Ferreira CV, Peppelenbosch MP, Spek CA.

    Oncogene. 2010 Dec 2;29(48):6314-22. Epub 2010 Aug 30.

    PMID:
    20802532
    [PubMed - indexed for MEDLINE]
    19.

    Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

    Matsuoka M, Jeang KT.

    Oncogene. 2011 Mar 24;30(12):1379-89. Epub 2010 Nov 29. Review.

    PMID:
    21119600
    [PubMed - indexed for MEDLINE]
    20.

    Trisomy 21 leukemias: finding the hits that matter.

    Rabson AB.

    Oncogene. 2010 Nov 18;29(46):6099-101. Epub 2010 Aug 16.

    PMID:
    20711238
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk